By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    bowl of vegetable salad
    Raw Foods: benefits and harms
    November 9, 2021
    pros and cons of the keto diet
    Read This Before You Follow the Keto Diet
    May 18, 2022
    spinal cord injuries
    4 Potential Causes of Spinal Cord Injuries (and How to Seek Compensation)
    May 25, 2022
    Latest News
    Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
    May 16, 2025
    Learn how to Renew your Medical Card in West Virginia
    May 16, 2025
    Choosing the Right Supplement Manufacturer for Your Brand
    May 1, 2025
    Engineering Temporary Hospitals for Extreme Weather
    April 24, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    4 Reasons Why Medical Device Compliance Matters
    May 22, 2020
    What To Know About The Importance Of Healthcare Marketing
    November 23, 2019
    healthcare courses
    6 Supplemental Courses in Healthcare to Support Your HR Degree
    August 20, 2021
    Latest News
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Advanced Cell OK’d to move forward with US trials
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Advanced Cell OK’d to move forward with US trials
Technology

Advanced Cell OK’d to move forward with US trials

HerinaAyot
Last updated: September 30, 2011 7:31 am
HerinaAyot
Share
4 Min Read
SHARE

Advanced Cell Technology (OTCBB:ACTC) said Wednesday that it has received approval from the independent Data and Safety Monitoring Board to move forward with enrolling and treating the next set of patients in each of its two US stem cell clinical trials.

In July, surgeons treated the first patients in the company’s clinical trials for Stargardt’s Macular Dystrophy (SMD), a degenerative eye disease seen in young people, and Dry Age-Related Macular Degeneration (Dry AMD), a degenerative disease causing vision loss in older people.

Advanced Cell Technology (OTCBB:ACTC) said Wednesday that it has received approval from the independent Data and Safety Monitoring Board to move forward with enrolling and treating the next set of patients in each of its two US stem cell clinical trials.

In July, surgeons treated the first patients in the company’s clinical trials for Stargardt’s Macular Dystrophy (SMD), a degenerative eye disease seen in young people, and Dry Age-Related Macular Degeneration (Dry AMD), a degenerative disease causing vision loss in older people.

More Read

Benefits of Smartphones in Managing Health Care
A Cardiologist in Your Pockets: HF Defender App for Heart Failure Patients
Medical Advancement: Innovation to Sports Injuries Treatments
2012 Medicare Physician Fee Schedule Final Rule Important for Telemedicine
Ready for the eyeSelfie for diagnosing health problems?

In both cases, eventually, severe vision loss and even blindness results from photoreceptor loss associated with degeneration in a layer of the retina, called the retinal pigment epithelium (RPE).

The company’s treatment uses retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs), which can potentially be used to supply an unlimited amount of healthy RPE cells to treat degenerative retinal diseases.

Each patient received an injection of 50,000 hESC-derived RPE cells in one of their eyes. Both the Dry AMD and SMD clinical trials are dose-escalation studies involving twelve patients in each, and are designed to evaluate the safety and tolerability of the injected RPE cells.

The study design involves four cohorts of three patients, each being treated at a pre-determined dose of RPE cells, ranging from 50,000 to 200,000 cells.

Based on the results of the first patient in each study, the independent board authorized the company to move forward with the next two patients in the studies. Each of these additional patients will also be treated with 50,000 RPE cells, the company said.

“The unanimous recommendation of the DSMB to proceed with the next four patients represents a significant milestone for our clinical programs,” said chief scientific officer, Dr. Robert Lanza.

“We hope that the positive trend in clinical results derived from treating the first patients with our RPE cells will continue.”
Chairman and CEO of Advanced Cell, Gary Rabin, added: “The outcome of this in-depth safety review by an unbiased team of experts is very reassuring.

“The DSMB, which includes independent experts in macular degeneration, has recommended that the study continue at the present dosage of cells. We hope that in the near future we will be able to share both safety and physiological data we are continuing to obtain in these trials.”

Last week, the company announced that health authorities in the UK gave the go-ahead for its stem cell trials to treat patients with Stargardt’s, the first time such studies have been approved in Europe. The UK trials will begin in December at the prolific Moorfields Eye Hospital in London, the oldest and largest eye hospital in the world, under Professor James Bainbridge, consultant surgeon and Chair of Retinal Studies at University College London.- Deborah Sterescu

 

TAGGED:Advanced Cell TechnologyDry AMDSMDstem cells
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Do You Grind Your Teeth at Night? Here’s How Night Guards and TMJ Treatments Can Help
Do You Grind Your Teeth at Night? Here’s How Night Guards and TMJ Treatments Can Help
Dental health
May 21, 2025
The Secret To A Confident Smile: Top Tips For Better Teeth
The Secret To A Confident Smile: Top Tips For Better Teeth
Dental health
May 21, 2025
Clinical Expertise
Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
Health care
May 18, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Health
May 15, 2025

You Might also Like

Mobile HealthTechnology

The Cloud Is Revolutionizing Healthcare

December 20, 2013
Tissue-cell_2010_2018
BusinessMedical InnovationsTechnology

Tissue Engineering and Cell Therapy Future Markets

October 25, 2011

How Improvements to Hearing Technology May Help Your Memory Care Practice

February 13, 2018

The Ministry of Health in Oman Moves from Analog to Digital Radiography

December 12, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?